切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2023, Vol. 09 ›› Issue (01) : 51 -53. doi: 10.3877/cma.j.issn.2095-9141.2023.01.010

综述

鞍区室管膜瘤的诊疗进展
何佳伟1, 张良1, 杨骐2, 高承天1, 王占祥1,()   
  1. 1. 361102 厦门,厦门大学附属第一医院神经外科
    2. 471003 洛阳,河南科技大学第一附属医院急诊科
  • 收稿日期:2022-03-09 出版日期:2023-02-15
  • 通信作者: 王占祥

Progress of diagnosis and treatment of sellar ependymoma

Jiawei He1, Liang Zhang1, Qi Yang2, Chengtian Gao1, Zhanxiang Wang1,()   

  1. 1. Department of Neurosurgery, the First Affiliated Hospital of Xiamen University, Xiamen 361102, China
    2. Department of Emergency, the First Affiliated Hospital of He'nan University of Science and Technology, Luoyang 471003, China
  • Received:2022-03-09 Published:2023-02-15
  • Corresponding author: Zhanxiang Wang
  • Supported by:
    National Natural Science Foundation of China(82072777); Key Medical and Health Projects in Xiamen(3502Z20209005)
引用本文:

何佳伟, 张良, 杨骐, 高承天, 王占祥. 鞍区室管膜瘤的诊疗进展[J/OL]. 中华神经创伤外科电子杂志, 2023, 09(01): 51-53.

Jiawei He, Liang Zhang, Qi Yang, Chengtian Gao, Zhanxiang Wang. Progress of diagnosis and treatment of sellar ependymoma[J/OL]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(01): 51-53.

鞍区室管膜瘤(SEP)是一种极其罕见的实体肿瘤,病例报道不多见。临床表现和影像学特征类似于无功能垂体腺瘤,确诊主要依赖术后组织病理学,目前尚无临床治疗指南,治疗方法以手术为主。本文结合相关文献对SEP的病因、发病机制、临床表现、诊断及治疗展开综述,以便更好地指导临床工作。

Sellar ependymoma (SEP) is an extremely rare solid tumor with few case reports. The clinical manifestations and imaging features are similar to non-functional pituitary adenomas. The diagnosis mainly depends on postoperative histopathology. Currently, there are no clinical treatment guidelines, and the treatment method is mainly surgery. This article mainly reviews the etiology, pathogenesis, clinical manifestations, diagnosis, and treatment of SEP based on the current related literature in order to better guide the clinical work.

[1]
Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016[J]. Neuro Oncol, 2019, 21(Suppl 5): v1-v100. DOI: 10.1093/neuonc/noz150.
[2]
Whipple SG, Savardekar AR, Rao S, et al. Primary tumors of the posterior pituitary gland: a systematic review of the literature in light of the new 2017 World Health Organization classification of pituitary tumors[J]. World Neurosurg, 2021, 145: 148-158. DOI: 10.1016/j.wneu.2020.09.023.
[3]
Shibuya M. Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors[J]. Brain Tumor Pathol, 2018, 35(2): 62-70. DOI: 10.1007/s10014-018-0311-6.
[4]
Zhao L, Jiang Y, Wang Y, et al. Case report: sellar ependymomas: a clinic-pathological study and literature review[J]. Front Endocrinol (Lausanne), 2021, 12: 551493. DOI: 10.3389/fendo.2021.551493.
[5]
Wang S, Zong W, Li Y, et al. Pituitary ependymoma: a case report and review of the literature[J]. World Neurosurg, 2018, 110: 43-54. DOI: 10.1016/j.wneu.2017.10.134.
[6]
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol, 2007, 114(2): 97-109. DOI: 10.1007/s00401-007-0243-4.
[7]
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary[J]. Neuro Oncol, 2021, 23(8): 1231-1251. DOI: 10.1093/neuonc/noab106.
[8]
Van Gompel JJ, Koeller KK, Meyer FB, et al. Cortical ependymoma: an unusual epileptogenic lesion[J]. J Neurosurg, 2011, 114(4): 1187-1194. DOI: 10.3171/2010.12.JNS10846.
[9]
Sarkisian SS, Schultz AL. Pituitary ependymoma[J]. U S Armed Forces Med J, 1956, 7(12): 1813-1816.
[10]
Takei Y, Seyama S, Pearl GS, et al. Ultrastructural study of the human neurohypophysis. II. Cellular elements of neural parenchyma, the pituicytes[J]. Cell Tissue Res, 1980, 205(2): 273-287. DOI: 10.1007/BF00234685.
[11]
Scheithauer BW, Swearingen B, Whyte ET, et al. Ependymoma of the sella turcica: a variant of pituicytoma[J]. Hum Pathol, 2009, 40(3): 435-40. DOI: 10.1016/j.humpath.2008.08.013.
[12]
McGuire CS, Sainani KL, Fisher PG. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study[J]. J Neurosurg, 2009, 110(4): 725-729. DOI: 10.3171/2008.9.JNS08117.
[13]
Parish JM, Bonnin JM, Goodman JM, et al. Intrasellar ependymoma: clinical, imaging, pathological, and surgical findings[J]. J Clin Neurosci, 2015, 22(4): 638-641. DOI: 10.1016/j.jocn.2014.10.026.
[14]
Asa SL, Mete O. What's new in pituitary pathology?[J]. Histopathology, 2018, 72(1): 133-141. DOI: 10.1111/his.13295.
[15]
Kumar PV. Nuclear grooves in ependymoma. Cytologic study of 21 cases[J]. Acta Cytol, 1997, 41(6): 1726-1731. DOI: 10.1159/000333176.
[16]
Belcher R, Chahal HS, Evanson J, et al. Recurrent pituitary ependymoma: a complex clinical problem[J]. Pituitary, 2010, 13(2): 176-182. DOI: 10.1007/s11102-008-0139-x.
[17]
Lee JS, Cho KH, Hong EK, et al. Pituitary ependymoma, 10-year follow-up after partial resection and radiation therapy[J]. Brain Tumor Res Treat, 2017, 5(2): 94-98. DOI: 10.14791/btrt.2017.5.2.94.
[18]
Guerrero-Pérez F, Marengo AP, Vidal N, et al. Primary tumors of the posterior pituitary: a systematic review[J]. Rev Endocr Metab Disord, 2019, 20(2): 219-238. DOI: 10.1007/s11154-019-09484-1.
[19]
Mukhida K, Asa S, Gentili F, et al. Ependymoma of the pituitary fossa. Case report and review of the literature[J]. J Neurosurg, 2006, 105(4): 616-620. DOI: 10.3171/jns.2006.105.4.616.
[20]
刘梦琦,刘有,陈志晔.鞍区室管膜瘤一例[J].中国医学科学院学报, 2019, 41(1): 139-142. DOI: 10.3881/j.issn.1000-503X.10397.
[21]
Thomson S, Chakrabarty A, Marks P. Ependymoma of the neurohypophysis[J]. Br J Neurosurg, 2001, 15(3): 277-278. DOI: 10.1080/026886901750353764.
[22]
Brat DJ, Scheithauer BW, Staugaitis SM, et al. Pituicytoma: a distinctive low-grade glioma of the neurohypophysis[J]. Am J Surg Pathol, 2000, 24(3): 362-368. DOI: 10.1097/00000478-200003000-00004.
[23]
Lukashova-v Zangen I, Kneitz S, Monoranu CM, et al. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival[J]. Acta Neuropathol, 2007, 113(3): 325-337. DOI: 10.1007/s00401-006-0190-5.
[24]
Valassi E, Biller BM, Klibanski A, et al. Clinical features of nonpituitary sellar lesions in a large surgical series[J]. Clin Endocrinol (Oxf), 2010, 73(6): 798-807. DOI: 10.1111/j.1365-2265.2010.03881.x.
[25]
赵冬梅,黄新文,梁爽.鞍区室管膜瘤一例[J].中华放射学杂志, 2010, 44(8): 895. DOI: 10.3760/cma.j.issn.1005-1201.2010.08.028.
[26]
Paulino AC, Wen BC, Buatti JM, et al. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure[J]. Am J Clin Oncol, 2002, 25(2): 117-122. DOI: 10.1097/00000421-200204000-00003.
[27]
Cole TS, Potla S, Sarris CE, et al. Rare thyroid transcription factor 1-positive tumors of the sellar region: Barrow neurological institute retrospective case series[J]. World Neurosurg, 2019, 129: e294-e302. DOI: 10.1016/j.wneu.2019.05.132.
[28]
Nagata Y, Inoshita N, Fukuhara N, et al. Low-grade glioma of the neurohypophysis: clinical characteristics and surgical outcomes[J]. World Neurosurg, 2018, 114: e1225-e1231. DOI: 10.1016/j.wneu.2018.03.180.
[29]
Yoshida K, Toda M, Akiyama T, et al. Combined endoscopic endonasal and video-microscopic transcranial approach with preoperative embolization for a posterior pituitary tumor[J]. World Neurosurg, 2018, 119: 201-208. DOI: 10.1016/j.wneu.2018.07.245.
[30]
Guerrero-Pérez F, Vidal N, Marengo AP, et al. Posterior pituitary tumours: the spectrum of a unique entity. A clinical and histological study of a large case series[J]. Endocrine, 2019, 63(1): 36-43. DOI: 10.1007/s12020-018-1774-2.
[31]
Lefevre E, Bouazza S, Bielle F, et al. Management of pituicytomas: a multicenter series of eight cases[J]. Pituitary, 2018, 21(5): 507-514. DOI: 10.1007/s11102-018-0905-3.
[32]
Zhang Y, Teng Y, Zhu H, et al. Granular cell tumor of the neurohypophysis: 3 cases and a systematic literature review of 98 cases[J]. World Neurosurg, 2018, 118: e621-e630. DOI: 10.1016/j.wneu.2018.07.004.
[33]
Mack SC, Witt H, Piro RM, et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy[J]. Nature, 2014, 506(7489): 445-450. DOI: 10.1038/nature13108.
[34]
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820. DOI: 10.1007/s00401-016-1545-1.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[3] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[6] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[7] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[8] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[9] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[10] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[11] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[12] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?